Lack of association between SLCO1B1 polymorphisms and lipid-lowering response to simvastatin therapy in Thai

N Kaewboonlert1, W Thitisopee2, W Sirintronsopon3

  • 1School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.

Insights

Genetic variations in SLCO1B1 (solute carrier organic anion transporter family member 1B1) did not predict simvastatin

Area of Science:

  • Pharmacogenomics
  • Cardiovascular Medicine
  • Molecular Biology

Background:

  • SLCO1B1 gene polymorphisms are known to influence statin therapy response.
  • Previous studies show inconsistent associations between SLCO1B1 variants and lipid-lowering effects.

Purpose of the Study:

  • To examine the impact of SLCO1B1 c.388A>G, c.521T>C, and g.89595T>C polymorphisms on simvastatin's lipid-lowering efficacy.
  • The study focused on Thai patients with hypercholesterolemia.

Main Methods:

  • Genotyping of SLCO1B1 polymorphisms (c.388A>G, c.521T>C, g.89595T>C) using PCR-HRM.
  • Analysis of serum lipid profiles (TC, TG, LDL-C, HDL-C) in 391 hypercholesterolemic patients before and after 3 or 12 months of simvastatin treatment (20-40 mg/day).

Main Results:

  • Simvastatin significantly reduced TC, TG, and LDL-C levels after 3 and 12 months (P < .05).
  • No significant changes in HDL-C levels were observed.
  • No association was found between the studied SLCO1B1 polymorphisms and the lipid-lowering response to simvastatin.

Conclusions:

  • The investigated SLCO1B1 polymorphisms (c.388A>G, c.521T>C, g.89595T>C) are unlikely to serve as reliable genetic markers for predicting simvastatin response in Thai hypercholesterolemic patients.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.5K
Vapor Pressure Lowering03:28

Vapor Pressure Lowering

The equilibrium vapor pressure of a liquid is the pressure exerted by its gaseous phase when vaporization and condensation are occurring at equal rates:
31.4K
What are Lipids?01:38

What are Lipids?

Overview
221.2K
Structure of Lipids03:38

Structure of Lipids

Lipids include a diverse group of compounds that are largely nonpolar in nature. This is because they are hydrocarbons that include mostly nonpolar carbon-carbon or carbon-hydrogen bonds. Non-polar molecules are hydrophobic (“water fearing”), or insoluble in water. Lipids perform many different functions in a cell. Cells store energy for long-term use in the form of fats. Lipids also provide insulation from the environment for plants and animals. For example, they help keep aquatic...
99.2K
Lipid Digestion01:06

Lipid Digestion

Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
99.8K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
18.6K